http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
MDxHealth Announces Independence Blue Cross Rendered Positive Medical Coverage Policy for ConfirmMDx
-
MDxHealth Announces Upgraded Revenue Forecast
-
MDxHealth and Teva Pharmaceuticals Sign Distribution Agreement for SelectMDx in Israel
-
MDxHealth Reports Second Quarter and First Half 2016 Results
-
MDxHealth Announces Positive Medical Policy for ConfirmMDx Issued by One of the Top Five Health Insurers in the US
-
MDxHealth and Cerba HealthCare Announce Collaboration Agreement for SelectMDx Commercialization
-
MDxHealth Secures New Reimbursement Coverage for SelectMDx
-
MDxHealth Contracts with Priority Health for Coverage of ConfirmMDx
-
MDxHealth Announces Agreement with Major Academic Medical Center for ConfirmMDx Testing
-
MDxHealth Announces European Urology Editorial Supporting SelectMDx Use in Detecting Prostate Cancer
-
MDxHealth (R): Grants QIAGEN Rights to MSP Technology for QIAsure Methylation Test for Cervical Cancer Risk
-
MDxHealth Secures First Reimbursement Coverage for SelectMDx
-
MDxHealth (R): Disclosure of the Number of Outstanding Voting Securities
-
MDxHealth's ConfirmMDx Stratifies Risk for Aggressive Prostate Cancer
-
MDxHealth Announces Positive Data Supporting Prognostic Value of ConfirmMDx and SelectMDx for Prostate Cancer
-
MDxHealth Provides First Quarter 2016 Business Update
-
MDxHealth's SelectMDx Study Published in European Urology
-
MDxHealth Partners with Andros Men's Clinic to Offer SelectMDx for Prostate Cancer
-
MDxHealth Launches SelectMDx "Liquid Biopsy" Test in the United States
-
MDxHealth Presents SelectMDx(TM) Results from Multicenter Validation Study at the 2016 Annual EAU Congress
-
MDxHealth Appoints Global Commercial Team for SelectMDx
-
MDxHealth Announces Inclusion of ConfirmMDx in 2016 NCCN Guidelines for Prostate Cancer Early Detection
-
MDxHealth Reports Fourth Quarter and Fiscal Year 2015 Results
-
MDxHealth Announces Conference Participation for First Half 2016
-
MDxHealth Receives 2016 Frost & Sullivan Global Prostate Cancer Diagnostics Technology Innovation Award
-
MDxHealth Analytical Validation Study on AssureMDx for Bladder Cancer Published in The Journal of Urology
-
MDxHealth Provides Preliminary Update on 2015 Results, Reporting Strong Sales Trajectory for ConfirmMDx
-
MDxHealth Announces Positive Data Supporting Expanded Diagnostic Application for ConfirmMDx for Prostate Cancer
-
MDxHealth Announces ConfirmMDx Marketing Partnership in Central/South America
-
MDxHealth to Participate in Prospective Clinical Validation Study with AssureMDx for Bladder Cancer
-
MDxHealth to Present at November 2015 Investor Conferences
-
MDxHealth to Present at November 2015 Investor Conferences
-
MDxHealth Provides Third Quarter 2015 Business Update
-
MDxHealth to Participate in Prospective 4M Clinical Study Evaluating Synergy of MRI and SelectMDx for Prostate Cancer
-
MDxHealth Launches SelectMDx "Liquid Biopsy" Test in Europe
-
MDxHealth Appoints Walter Narajowski as Independent Director
-
MDxHealth(R): Completion of the acquisition of NovioGendix - New share capital amount and new number of shares
-
MDxHealth's ConfirmMDx Covered by Tufts Health Plan
-
MDxHealth Acquires NovioGendix to Expand Uro-Oncology Product Offering
-
MDxHealth Reports New ConfirmMDx Risk Score Data at 11th World Congress on Urological Research
-
MDxHealth Reports First Half 2015 Results
-
MDxHealth Announces Positive Top-Line Data for its Liquid Biopsy Test for Bladder Cancer
-
MDxHealth Appoints Philip J. Ginsburg M.D. as Chief Medical Officer
-
MDxHealth's ConfirmMDx(r) Predicts Prostate Cancer Aggressiveness
-
MDxHealth Provides First Quarter 2015 Business Update
-
MDxHealth Named Winner of Corporate LiveWire Innovation & Excellence 2015 Award
-
MDxHealth Completes Enrollment of Second ConfirmMDx Clinical Utility Study

